Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT): Open Label

NCT07689773 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT07689773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07689773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT): Open Label
Lead sponsor
Medical University of South Carolina
Phase
Phase 2
Overall status
Recruiting
Start date
July 10, 2026
Completion date
June 30, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

olfactory impairment